CpG-ODNs induced changes in cytokine/chemokines genes expression associated with suppression of infectious bronchitis virus replication in chicken lungs

Veterinary Immunology and Immunopathology

Volumn 160, Issue 3-4, 2014, Pages 209-217

  Dar, Arshud ^a   Tikoo, Suresh ^a   Potter, Andy ^a   Babiuk, Lorne A ^b   Townsend, Hugh ^a   Gerdts, Volker ^a   Mutwiri, George ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Avian infectious bronchitis virus; CpG ODN cytokines chemokines; Inhibition of virus replication

Indexed keywords

CHEMOKINE; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; AVIAN PROTEIN; CPG-OLIGONUCLEOTIDE; MESSENGER RNA; NUCLEOCAPSID PROTEIN; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL TISSUE; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; CHICK; CHICKEN; EGG; EMBRYO; FETUS LUNG; GENE EXPRESSION; IMMUNOMODULATION; INNATE IMMUNITY; LUNG PARENCHYMA; NONHUMAN; UPREGULATION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; ANIMAL; CHICK EMBRYO; CPG ISLAND; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS GENE;

AVIAN INFECTIOUS BRONCHITIS VIRUS; GALLUS GALLUS; SPONDIAS PURPUREA;

ANIMALS; AVIAN PROTEINS; CHEMOKINE CCL4; CHEMOKINES; CHICK EMBRYO; CHICKENS; CPG ISLANDS; CYTOKINES; GENE EXPRESSION; GENES, VIRAL; IMMUNITY, INNATE; INFECTIOUS BRONCHITIS VIRUS; INTERFERON-GAMMA; INTERLEUKIN-8; LUNG; NUCLEOCAPSID PROTEINS; OLIGODEOXYRIBONUCLEOTIDES; RNA, MESSENGER; VIRUS REPLICATION;

EID: 84928939922     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2014.05.004     Document Type: Article

References (58)

1. Andrews D.M., Estcourt M.J., Andoniou C.E., Wikstrom M.E., Khong A., Voigt V., Fleming P., Tabarias H., Hill G.R., van der Most R.G., Scalzo A.A., Smyth M.J., Degli-Esposti M.A. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 2010, 207:1333-1343.
2. Banat G.R., Tkalcic S., Dzielawa J.A., Jackwood M.W., Saggese M.D., Yates L., Kopulos R., Briles W.E., Collisson E.W. Association of the chicken MHC B haplotypes with resistance to avian coronavirus. Dev. Comp. Immunol. 2013, 39:430-437.
3. Banerjee S., Narayanan K., Mizutani T., Makino S. Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells. J. Virol. 2002, 76:5937-5948.
4. Bianco A., Whiteman S.C., Sethi S.K., Allen J.T., Knight R.A., Spiteri M.A. Expression of intercellular adhesion molecule-1 (ICAM-1) in nasal epithelial cells of atopic subjects: a mechanism for increased rhinovirus infection?. Clin. Exp. Immunol. 2000, 121:339-345.
5. Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol. 2003, 32:567-582.
6. Cavanaugh V.J., Guidotti L.G., Chisari F.V. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J. Virol. 1997, 71:3236-3243.
7. Cheung C.Y., Poon L.L., Ng I.H., Luk W., Sia S.F., Wu M.H., Chan K.H., Yuen K.Y., Gordon S., Guan Y., Peiris J.S. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J. Virol. 2005, 79:7819-7826.
8. Dar A., Allan B., Gomis S., Potter A.G.M. immunotherapeutic potentials of CpG oligonucleotides in chickens. J. Poult. Sci. 2009, 46:69-80.
9. Dar A., Potter A., Tikoo S., Gerdts V., Lai K., Babiuk L.A., Mutwiri G. CpG oligodeoxynucleotides activate innate immune response that suppresses infectious bronchitis virus replication in chicken embryos. Avian Dis. 2009, 53:261-267.
10. Estcourt M.J., Ramshaw A., Ramsay A.J. Cytokine responses in virus infections: effects on pathogenesis, recovery and persistence. Curr. Opin. Microbiol. 1998, 1:411-418.
11. Fearon D.T. Innate immunity-beginning to fulfill its promise?. Nat. Immunol. 2000, 1:102-103.
12. Glass W.G., Subbarao K., Murphy B., Murphy P.M. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J. Immunol. 2004, 173:4030-4039.
13. Gomis S., Babiuk L., Allan B., Willson P., Waters E., Ambrose N., Hecker R., Potter A. Protection of neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine-phosphodiester-guanine motifs. Avian Dis. 2004, 48:813-822.
14. Gomis S., Babiuk L., Allan B., Willson P., Waters E., Hecker R., Potter A. Protection of chickens against a lethal challenge of Escherichia coli by a vaccine containing CpG oligodeoxynucleotides as an adjuvant. Avian Dis. 2007, 51:78-83.
15. Guo X., Rosa A.J., Chen D.G., Wang X. Molecular mechanisms of primary and secondary mucosal immunity using avian infectious bronchitis virus as a model system. Vet. Immunol. Immunopathol. 2008, 121:332-343.
16. Hackney K., Cavanagh D., Kaiser P., Britton P. In vitro and in ovo expression of chicken gamma interferon by a defective RNA of avian coronavirus infectious bronchitis virus. J. Virol. 2003, 77:5694-5702.
17. Han J.Q., Townsend H.L., Jha B.K., Paranjape J.M., Silverman R.H., Barton D.J. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. J. Virol. 2007, 81:5561-5572.
18. He H., Genovese K.J., Swaggerty C.L., MacKinnon K.M., Kogut M.H. Co-stimulation with TLR3 and TLR21 ligands synergistically up-regulates Th1-cytokine IFN-gamma and regulatory cytokine IL-10 expression in chicken monocytes. Dev. Comp. Immunol. 2012, 36:756-760.
19. Hendley J.O. The host response, not the virus, causes the symptoms of the common cold. Clin. Infect. Dis. 1998, 26:847-848.
20. Hogan S.P., Foster P.S., Tan X., Ramsay A.J. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur. J. Immunol. 1998, 28:413-423.
21. Hooks J.J., Wang Y., Detrick B. The critical role of IFN-gamma in experimental coronavirus retinopathy. Invest. Ophthalmol. Visual Sci. 2003, 44:3402-3408.
22. Huang K.J., Su I.J., Theron M., Wu Y.C., Lai S.K., Liu C.C., Lei H.Y. An interferon-gamma-related cytokine storm in SARS patients. J. Med. Virol. 2005, 75:185-194.
23. Hurgin V., Novick D., Werman A., Dinarello C.A., Rubinstein M. Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha. Proc. Nat. Acad. Sci. U.S.A. 2007, 104:5044-5049.
24. Jackwood M.W., Rosenbloom R., Petteruti M., Hilt D.A., McCall A.W., Williams S.M. Avian coronavirus infectious bronchitis virus susceptibility to botanical oleoresins and essential oils in vitro and in vivo. Virus Res. 2010, 149:86-94.
25. Jiang Y., Xu J., Zhou C., Wu Z., Zhong S., Liu J., Luo W., Chen T., Qin Q., Deng P. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 2005, 171:850-857.
26. Kimura H., Yoshizumi M., Ishii H., Oishi K., Ryo A. Cytokine production and signaling pathways in respiratory virus infection. Front Microbiol. 2013, 4:276.
27. Kopecky-Bromberg S.A., Martinez-Sobrido L., Frieman M., Baric R.A., Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 2007, 81:548-557.
28. Lee C.W., Jackwood M.W. Evidence of genetic diversity generated by recombination among avian coronavirus IBV. Arch. Virol. 2000, 145:2135-2148.
29. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
30. Lowenthal J.W., O'Neil T.E., Broadway M., Strom A.D., Digby M.R., Andrew M., York J.J. Coadministration of IFN-gamma enhances antibody responses in chickens. J. Interferon Cytokine Res. 1998, 18:617-622.
31. Lowenthal J.W., York J.J., O'Neil T.E., Steven R.A., Strom D.G., Digby M.R. Potential use of cytokine therapy in poultry. Vet. Immunol. Immunopathol. 1998, 63:191-198.
32. Martinand C., Montavon C., Salehzada T., Silhol M., Lebleu B., Bisbal C. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J. Virol. 1999, 73:290-296.
33. Martinand C., Salehzada T., Silhol M., Lebleu B., Bisbal C. RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. Eur. J. Biochem. 1998, 254:248-255.
34. Mogensen T.H., Paludan S.R. Molecular pathways in virus-induced cytokine production. Microbiol. Mol. Biol. Rev. 2001, 65:131-150.
35. Narayanan K., Huang C., Lokugamage K., Kamitani W., Ikegami T., Tseng C.T., Makino S. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J. Virol. 2008, 82:4471-4479.
36. Perlman S., Dandekar A.A. Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 2005, 5:917-927.
37. Raj G.D., Jones R.C. Infectious bronchitis virus: immunopathogenesis of infection in the chicken. Avian Pathol. 1997, 26:677-706.
38. Raj G.D., Savage C.E., Jones R.C. Effect of heterophil depletion by 5-fluorouracil on infectious bronchitis virus infection in chickens. Avian Pathol. 1997, 26:427-432.
39. Reghunathan R., Jayapal M., Hsu L.Y., Chng H.H., Tai D., Leung B.P., Melendez A.J. Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol. 2005, 6:2.
40. Rossol S., Marinos G., Carucci P., Singer M.V., Williams R., Naoumov N.V. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Invest. 1997, 99:3025-3033.
41. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14:778-809. (table of contents).
42. Schijns V.E., Wierda C.M., van Hoeij M., Horzinek M.C. Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12. J. Immunol. 1996, 157:815-821.
43. Sethi S.K., Bianco A., Allen J.T., Knight R.A., Spiteri M.A. Interferon-gamma (IFN-gamma) down-regulates the rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells. Clin. Exp. Immunol. 1997, 110:362-369.
44. Silverman R.H. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 2007, 81:12720-12729.
45. Sims A.C., Burkett S.E., Yount B., Pickles R.J. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium. Virus Res. 2008, 133:33-44.
46. Spiegel M., Pichlmair A., Martinez-Sobrido L., Cros J., Garcia-Sastre A., Haller O., Weber F. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol. 2005, 79:2079-2086.
47. Spiegel M., Weber F. Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. Virol. J. 2006, 3:17.
48. Tanaka Y., Sato Y., Sasaki T. Suppression of coronavirus replication by cyclophilin inhibitors. Viruses 2013, 5:1250-1260.
49. Tohya Y., Narayanan K., Kamitani W., Huang C., Lokugamage K., Makino S. Suppression of host gene expression by nsp1 proteins of group 2 bat coronaviruses. J. Virol. 2009, 83:5282-5288.
50. Tseng C.T., Perrone L.A., Zhu H., Makino S., Peters C.J. Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J. Immunol. 2005, 174:7977-7985.
51. Wang W.K., Chen S.Y., Liu I.J., Kao C.L., Chen H.L., Chiang B.L., Wang J.T., Sheng W.H., Hsueh P.R., Yang C.F., Yang P.C., Chang S.C. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clin. Infect. Dis. 2004, 39:1071-1075.
52. Yoshikawa T., Hill T., Li K., Peters C.J., Tseng C.T. Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells. J. Virol. 2009, 83:3039-3048.
53. Yoshikawa T., Hill T.E., Yoshikawa N., Popov V.L., Galindo C.L., Garner H.R., Peters C.J., Tseng C.T. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS One 2010, 5:e8729.
54. Young H.A., Bream J.H. IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications. Curr. Top. Microbiol. Immunol. 2007, 316:97-117.
55. Young H.A., Ghosh P. Molecular regulation of cytokine gene expression: interferon-gamma as a model system. Prog. Nucleic Acid Res. Mol. Biol. 1997, 56:109-127.
56. Zhang R., Jha B.K., Ogden K.M., Dong B., Zhao L., Elliott R., Patton J.T., Silverman R.H., Weiss S.R. Homologous 2',5'-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity. Proc. Nat. Acad. Sci. U.S.A. 2013, 110:13114-13119.
57. Zhang Y., Li J., Zhan Y., Wu L., Yu X., Zhang W., Ye L., Xu S., Sun R., Wang Y., Lou J. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect. Immun. 2004, 72:4410-4415.
58. Zhao L., Jha B.K., Wu A., Elliott R., Ziebuhr J., Gorbalenya A.E., Silverman R.H., Weiss S.R. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 2012, 11:607-616.